Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
This study determines patterns of cannabis use among cancer patients. Information collected in this study may help doctors to understand patient use of cannabis therapy, their knowledge and experiences with this therapy, benefits and risks associated with its use, and whether or to what extent they are discussing it with their health care providers.
Detailed description
PRIMARY OBJECTIVES: I. To identify the frequency, modes, and duration of cannabis use, assess experiences with obtaining and using cannabis, as well as reasons for use and perceived risks and benefits of its use among cancer patients who are undergoing or have recently completed active treatment. Ia. To uncover disparities in use of cannabis, perceptions of use, and communication with providers among cancer patients who are identify as racial and ethnic minorities, have low health or digital literacy, are of older age or low socioeconomic status. II. Among cancer patients with a known medical marijuana certification, assess the impact of cannabis on pain management, anxiety, anorexia, and quality of life, as well as their communication with their oncology team about their procurement and use of cannabis. OUTLINE: Patients complete a survey about knowledge and awareness of medical cannabis, perceived risks and benefits of cannabis, mode and frequency of use (if applicable), impact on cancer-related symptoms, patient provider discussions about cannabis, and demographic characteristics including health and digital literacy.
Interventions
Complete a Survey
Sponsors
Study design
Eligibility
Inclusion criteria
* Provide signed and dated informed consent form * English speaking * Willing to comply with all study procedures and be available for the duration of the study * Any individual \>= 18 years old * At least one medical or radiation oncology appoint within the last 3 years at one of the SKCC cancer center campuses
Exclusion criteria
* Non-English speaking * Not a cancer patient at one of the SKCC campuses * Deceased
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survey data analysis | Up to 12 months | Respondent demographics and clinical characteristics and survey responses |
Countries
United States